Titre : Sondes d'acide nucléique

Sondes d'acide nucléique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Platelet Function Tests
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Sondes d'acide nucléique : Questions médicales les plus fréquentes", "headline": "Sondes d'acide nucléique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Sondes d'acide nucléique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-17", "dateModified": "2025-02-11", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Sondes d'acide nucléique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Sondes moléculaires", "url": "https://questionsmedicales.fr/mesh/D015335", "about": { "@type": "MedicalCondition", "name": "Sondes moléculaires", "code": { "@type": "MedicalCode", "code": "D015335", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Éléments antisens (génétique)", "alternateName": "Antisense Elements (Genetics)", "url": "https://questionsmedicales.fr/mesh/D016375", "about": { "@type": "MedicalCondition", "name": "Éléments antisens (génétique)", "code": { "@type": "MedicalCode", "code": "D016375", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "ADN antisens", "alternateName": "DNA, Antisense", "url": "https://questionsmedicales.fr/mesh/D016373", "about": { "@type": "MedicalCondition", "name": "ADN antisens", "code": { "@type": "MedicalCode", "code": "D016373", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150.200" } } }, { "@type": "MedicalWebPage", "name": "Oligonucléotides antisens", "alternateName": "Oligonucleotides, Antisense", "url": "https://questionsmedicales.fr/mesh/D016376", "about": { "@type": "MedicalCondition", "name": "Oligonucléotides antisens", "code": { "@type": "MedicalCode", "code": "D016376", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150.640" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Oligodésoxyribonucléotides antisens", "alternateName": "Oligodeoxyribonucleotides, Antisense", "url": "https://questionsmedicales.fr/mesh/D020319", "about": { "@type": "MedicalCondition", "name": "Oligodésoxyribonucléotides antisens", "code": { "@type": "MedicalCode", "code": "D020319", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150.640.640" } } } ] }, { "@type": "MedicalWebPage", "name": "Oligodésoxyribonucléotides antisens", "alternateName": "Oligodeoxyribonucleotides, Antisense", "url": "https://questionsmedicales.fr/mesh/D020319", "about": { "@type": "MedicalCondition", "name": "Oligodésoxyribonucléotides antisens", "code": { "@type": "MedicalCode", "code": "D020319", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150.640.640" } } }, { "@type": "MedicalWebPage", "name": "ARN antisens", "alternateName": "RNA, Antisense", "url": "https://questionsmedicales.fr/mesh/D016372", "about": { "@type": "MedicalCondition", "name": "ARN antisens", "code": { "@type": "MedicalCode", "code": "D016372", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150.760" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Oligoribonucléotides antisens", "alternateName": "Oligoribonucleotides, Antisense", "url": "https://questionsmedicales.fr/mesh/D020320", "about": { "@type": "MedicalCondition", "name": "Oligoribonucléotides antisens", "code": { "@type": "MedicalCode", "code": "D020320", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150.760.645" } } } ] }, { "@type": "MedicalWebPage", "name": "Oligoribonucléotides antisens", "alternateName": "Oligoribonucleotides, Antisense", "url": "https://questionsmedicales.fr/mesh/D020320", "about": { "@type": "MedicalCondition", "name": "Oligoribonucléotides antisens", "code": { "@type": "MedicalCode", "code": "D020320", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150.760.645" } } } ] }, { "@type": "MedicalWebPage", "name": "Sondes d'ADN", "alternateName": "DNA Probes", "url": "https://questionsmedicales.fr/mesh/D015342", "about": { "@type": "MedicalCondition", "name": "Sondes d'ADN", "code": { "@type": "MedicalCode", "code": "D015342", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.223" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "ADN complémentaire", "alternateName": "DNA, Complementary", "url": "https://questionsmedicales.fr/mesh/D018076", "about": { "@type": "MedicalCondition", "name": "ADN complémentaire", "code": { "@type": "MedicalCode", "code": "D018076", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.223.260" } } }, { "@type": "MedicalWebPage", "name": "Amorces ADN", "alternateName": "DNA Primers", "url": "https://questionsmedicales.fr/mesh/D017931", "about": { "@type": "MedicalCondition", "name": "Amorces ADN", "code": { "@type": "MedicalCode", "code": "D017931", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.223.600" } } }, { "@type": "MedicalWebPage", "name": "Sondes d'ADN spécifiques des gènes HLA", "alternateName": "DNA Probes, HLA", "url": "https://questionsmedicales.fr/mesh/D015343", "about": { "@type": "MedicalCondition", "name": "Sondes d'ADN spécifiques des gènes HLA", "code": { "@type": "MedicalCode", "code": "D015343", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.223.615" } } }, { "@type": "MedicalWebPage", "name": "Sondes d'ADN spécifiques du VPH", "alternateName": "DNA Probes, HPV", "url": "https://questionsmedicales.fr/mesh/D015344", "about": { "@type": "MedicalCondition", "name": "Sondes d'ADN spécifiques du VPH", "code": { "@type": "MedicalCode", "code": "D015344", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.223.620" } } } ] }, { "@type": "MedicalWebPage", "name": "Sondes oligonucléotidiques", "alternateName": "Oligonucleotide Probes", "url": "https://questionsmedicales.fr/mesh/D015345", "about": { "@type": "MedicalCondition", "name": "Sondes oligonucléotidiques", "code": { "@type": "MedicalCode", "code": "D015345", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.650" } } }, { "@type": "MedicalWebPage", "name": "Sondes d'ARN", "alternateName": "RNA Probes", "url": "https://questionsmedicales.fr/mesh/D015347", "about": { "@type": "MedicalCondition", "name": "Sondes d'ARN", "code": { "@type": "MedicalCode", "code": "D015347", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.825" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "ARN complémentaire", "alternateName": "RNA, Complementary", "url": "https://questionsmedicales.fr/mesh/D018075", "about": { "@type": "MedicalCondition", "name": "ARN complémentaire", "code": { "@type": "MedicalCode", "code": "D018075", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.825.840" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Sondes d'acide nucléique", "alternateName": "Nucleic Acid Probes", "code": { "@type": "MedicalCode", "code": "D015341", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Na Li", "url": "https://questionsmedicales.fr/author/Na%20Li", "affiliation": { "@type": "Organization", "name": "College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Institute of Molecular and Nano Science, Shandong Normal University, Jinan, 250014, P. R. China." } }, { "@type": "Person", "name": "Ru Sun", "url": "https://questionsmedicales.fr/author/Ru%20Sun", "affiliation": { "@type": "Organization", "name": "College of Chemistry, Chemical Engineering and Material Science, Soochow University, 199 Ren'Ai Road, 215123, Suzhou, China." } }, { "@type": "Person", "name": "Yu-Jie Xu", "url": "https://questionsmedicales.fr/author/Yu-Jie%20Xu", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, 215123, Suzhou, China." } }, { "@type": "Person", "name": "Jian-Feng Ge", "url": "https://questionsmedicales.fr/author/Jian-Feng%20Ge", "affiliation": { "@type": "Organization", "name": "College of Chemistry, Chemical Engineering and Material Science, Soochow University, 199 Ren'Ai Road, 215123, Suzhou, China. ge_jianfeng@hotmail.com." } }, { "@type": "Person", "name": "Bo Tang", "url": "https://questionsmedicales.fr/author/Bo%20Tang", "affiliation": { "@type": "Organization", "name": "College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Institute of Molecular and Nano Science, Shandong Normal University, Jinan, 250014, P. R. China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Validation of immunofluorescence analysis of blood smears in patients with inherited platelet disorders.", "datePublished": "2023-01-10", "url": "https://questionsmedicales.fr/article/36732160", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jtha.2022.12.031" } }, { "@type": "ScholarlyArticle", "name": "The rate of platelet activation determines thrombus size and structure at arterial shear.", "datePublished": "2023-04-19", "url": "https://questionsmedicales.fr/article/37085037", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jtha.2023.03.044" } }, { "@type": "ScholarlyArticle", "name": "Platelet inhibition by low-dose aspirin is not influenced by body mass or weight.", "datePublished": "2022-06-29", "url": "https://questionsmedicales.fr/article/35768902", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/09537104.2022.2087868" } }, { "@type": "ScholarlyArticle", "name": "Platelet dysfunction persists after trauma despite balanced blood product resuscitation.", "datePublished": "2022-10-22", "url": "https://questionsmedicales.fr/article/36280503", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.surg.2022.09.017" } }, { "@type": "ScholarlyArticle", "name": "Time from blood draw to multiple electrode aggregometry and association with platelet reactivity.", "datePublished": "2022-11-08", "url": "https://questionsmedicales.fr/article/36344849", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11239-022-02720-7" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Actions chimiques et utilisations", "item": "https://questionsmedicales.fr/mesh/D020164" }, { "@type": "ListItem", "position": 3, "name": "Utilisations spécialisées de produits chimiques", "item": "https://questionsmedicales.fr/mesh/D020313" }, { "@type": "ListItem", "position": 4, "name": "Produits chimiques de laboratoire", "item": "https://questionsmedicales.fr/mesh/D019995" }, { "@type": "ListItem", "position": 5, "name": "Sondes moléculaires", "item": "https://questionsmedicales.fr/mesh/D015335" }, { "@type": "ListItem", "position": 6, "name": "Sondes d'acide nucléique", "item": "https://questionsmedicales.fr/mesh/D015341" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Sondes d'acide nucléique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Sondes d'acide nucléique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Sondes d'acide nucléique", "description": "Comment les sondes d'acide nucléique sont-elles utilisées en diagnostic ?\nQuelles maladies peuvent être détectées avec des sondes ?\nQuel est le principe de fonctionnement des sondes ?\nLes sondes peuvent-elles détecter des mutations génétiques ?\nQuel type d'échantillons est utilisé pour les sondes ?", "url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Platelet+Function+Tests&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Sondes d'acide nucléique", "description": "Les sondes d'acide nucléique révèlent-elles des symptômes ?\nPeut-on utiliser des sondes pour surveiller des symptômes ?\nLes sondes peuvent-elles aider à prédire des symptômes ?\nLes sondes sont-elles liées à des symptômes spécifiques ?\nComment les sondes aident-elles à comprendre les symptômes ?", "url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Platelet+Function+Tests&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Sondes d'acide nucléique", "description": "Les sondes d'acide nucléique jouent-elles un rôle préventif ?\nComment les sondes aident-elles à la prévention des maladies ?\nPeut-on utiliser des sondes pour la vaccination ?\nLes sondes peuvent-elles détecter des infections précoces ?\nLes sondes sont-elles utilisées dans les programmes de santé publique ?", "url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Platelet+Function+Tests&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Sondes d'acide nucléique", "description": "Les sondes d'acide nucléique sont-elles utilisées en traitement ?\nComment les sondes influencent-elles le choix du traitement ?\nPeut-on développer des traitements basés sur des sondes ?\nLes sondes aident-elles à surveiller l'efficacité des traitements ?\nLes sondes sont-elles utilisées dans les essais cliniques ?", "url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Platelet+Function+Tests&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Sondes d'acide nucléique", "description": "Les sondes d'acide nucléique peuvent-elles causer des complications ?\nQuelles complications peuvent survenir avec des sondes ?\nLes sondes peuvent-elles entraîner des effets secondaires ?\nComment minimiser les complications liées aux sondes ?\nLes sondes sont-elles fiables pour éviter des complications ?", "url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Platelet+Function+Tests&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Sondes d'acide nucléique", "description": "Quels facteurs de risque sont associés à l'utilisation des sondes ?\nLes sondes sont-elles influencées par des facteurs environnementaux ?\nL'âge est-il un facteur de risque pour l'utilisation des sondes ?\nLes habitudes de vie influencent-elles les résultats des sondes ?\nLes sondes sont-elles affectées par des facteurs génétiques ?", "url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Platelet+Function+Tests&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment les sondes d'acide nucléique sont-elles utilisées en diagnostic ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Elles permettent d'identifier des séquences génétiques spécifiques liées à des maladies." } }, { "@type": "Question", "name": "Quelles maladies peuvent être détectées avec des sondes ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont utilisées pour détecter des infections virales, bactériennes et des cancers." } }, { "@type": "Question", "name": "Quel est le principe de fonctionnement des sondes ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Elles se lient spécifiquement à des séquences cibles, permettant leur détection par hybridation." } }, { "@type": "Question", "name": "Les sondes peuvent-elles détecter des mutations génétiques ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines sondes sont conçues pour identifier des mutations spécifiques dans l'ADN." } }, { "@type": "Question", "name": "Quel type d'échantillons est utilisé pour les sondes ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des échantillons de sang, de tissus ou de fluides corporels peuvent être analysés." } }, { "@type": "Question", "name": "Les sondes d'acide nucléique révèlent-elles des symptômes ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Non, elles détectent des séquences génétiques, pas des symptômes cliniques." } }, { "@type": "Question", "name": "Peut-on utiliser des sondes pour surveiller des symptômes ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Indirectement, en surveillant des biomarqueurs associés à des symptômes spécifiques." } }, { "@type": "Question", "name": "Les sondes peuvent-elles aider à prédire des symptômes ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent indiquer un risque accru de maladies, mais pas de symptômes immédiats." } }, { "@type": "Question", "name": "Les sondes sont-elles liées à des symptômes spécifiques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont liées à des maladies, qui peuvent avoir des symptômes variés." } }, { "@type": "Question", "name": "Comment les sondes aident-elles à comprendre les symptômes ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Elles aident à identifier les causes génétiques sous-jacentes des symptômes observés." } }, { "@type": "Question", "name": "Les sondes d'acide nucléique jouent-elles un rôle préventif ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Indirectement, en permettant le dépistage précoce de maladies génétiques ou infectieuses." } }, { "@type": "Question", "name": "Comment les sondes aident-elles à la prévention des maladies ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Elles permettent d'identifier les individus à risque et de mettre en place des mesures préventives." } }, { "@type": "Question", "name": "Peut-on utiliser des sondes pour la vaccination ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent aider à développer des vaccins en identifiant des cibles immunogènes." } }, { "@type": "Question", "name": "Les sondes peuvent-elles détecter des infections précoces ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont efficaces pour détecter des infections à un stade précoce." } }, { "@type": "Question", "name": "Les sondes sont-elles utilisées dans les programmes de santé publique ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont intégrées dans des programmes de dépistage et de surveillance épidémiologique." } }, { "@type": "Question", "name": "Les sondes d'acide nucléique sont-elles utilisées en traitement ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elles ne sont pas des traitements, mais aident à guider les choix thérapeutiques." } }, { "@type": "Question", "name": "Comment les sondes influencent-elles le choix du traitement ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Elles identifient des cibles spécifiques, permettant des thérapies ciblées adaptées." } }, { "@type": "Question", "name": "Peut-on développer des traitements basés sur des sondes ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des traitements peuvent être développés pour cibler des séquences spécifiques." } }, { "@type": "Question", "name": "Les sondes aident-elles à surveiller l'efficacité des traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent être utilisées pour évaluer la réponse au traitement au niveau moléculaire." } }, { "@type": "Question", "name": "Les sondes sont-elles utilisées dans les essais cliniques ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont souvent utilisées pour évaluer des biomarqueurs dans les essais cliniques." } }, { "@type": "Question", "name": "Les sondes d'acide nucléique peuvent-elles causer des complications ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont généralement sûres, mais des erreurs de diagnostic peuvent entraîner des complications." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des sondes ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des complications peuvent inclure des faux positifs ou négatifs, affectant le traitement." } }, { "@type": "Question", "name": "Les sondes peuvent-elles entraîner des effets secondaires ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elles n'ont pas d'effets secondaires directs, mais des erreurs peuvent avoir des conséquences." } }, { "@type": "Question", "name": "Comment minimiser les complications liées aux sondes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "En utilisant des protocoles de test rigoureux et en validant les résultats obtenus." } }, { "@type": "Question", "name": "Les sondes sont-elles fiables pour éviter des complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont généralement fiables, mais leur précision dépend de la qualité des échantillons." } }, { "@type": "Question", "name": "Quels facteurs de risque sont associés à l'utilisation des sondes ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux de maladies génétiques ou infectieuses." } }, { "@type": "Question", "name": "Les sondes sont-elles influencées par des facteurs environnementaux ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs comme l'exposition à des agents pathogènes peuvent influencer les résultats." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque pour l'utilisation des sondes ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies détectées par sondes sont plus fréquentes chez les personnes âgées." } }, { "@type": "Question", "name": "Les habitudes de vie influencent-elles les résultats des sondes ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes comme le tabagisme peuvent affecter la santé et les résultats des tests." } }, { "@type": "Question", "name": "Les sondes sont-elles affectées par des facteurs génétiques ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des variations génétiques peuvent influencer la sensibilité et la spécificité des sondes." } } ] } ] }

Sources (10000 au total)

Validation of immunofluorescence analysis of blood smears in patients with inherited platelet disorders.

Inherited platelet disorders (IPDs) are rare diseases characterized by reduced blood platelet counts and/or impaired platelet function. Recognizing IPDs is advisable but often challenging. The diagnos... The aim of the present study was to validate immunofluorescence microscopy as a screening tool for IPDs in comparison with genetic screening.... We performed a blinded comparison between the diagnosis made using immunofluorescence microscopy on blood smears and genetic findings in a cohort of 43 families affected with 20 different genetically ... Immunofluorescence correctly predicted the underlying IPD in the vast majority of patients with 1 of 9 IPDs for which the typical morphologic pattern is known. Thirty of the 43 enrolled families (70%)... Immunofluorescence microscopy on blood smears is an effective screening tool for 9 forms of IPD, which include the most frequent forms of inherited thrombocytopenia. Using this approach, typical chang...

The rate of platelet activation determines thrombus size and structure at arterial shear.

The response of platelets to activating stimuli and pharmaceutical agents varies greatly within the normal population. Current platelet function tests are used to measure end-point levels of platelet ... To identify variability, to agonists and among individuals, in platelet activation kinetics and assess the impact of this on thrombus formation.... We have developed a bespoke real-time flow cytometry assay and analysis package to measure the rate of platelet activation over time using 2 parameters of platelet activation, fibrinogen binding and P... The rate of platelet activation varied considerably within the normal population but did not correlate with maximal platelet activation, demonstrating that platelet activation rate is a separate and n... For the first time, we have shown that platelet response rate corresponds to thrombus size and structure, wherein faster responders form larger, more densely packed thrombi at arterial, but crucially ...

Platelet dysfunction persists after trauma despite balanced blood product resuscitation.

Platelet activation and aggregation are critical to the initiation of hemostasis after trauma with hemorrhage. Platelet dysfunction is a well-recognized phenomenon contributing to trauma-induced coagu... A retrospective secondary cohort study of platelet count and function was performed using samples from the Pragmatic Randomized Optimal Platelet and Plasma Ratios trial. Platelet characteristics were ... In total, 680 patients were included for analysis. Platelet counts were significantly lower from baseline to 72 hours after hospital admission with further 1.3 to 2-fold reductions noted in nonsurvivo... Platelet aggregability recovers 12 hours after injury independent of worsening thrombocytopenia. Failure of platelet function to recover portends a poor prognosis....

Effect of P2Y12 platelet reactivity level on peri- and postoperative outcomes of cardiac surgery patients.

Evidence surrounding P2Y12 platelet reactivity units (PRU) impact on bleeding outcomes in patients undergoing coronary artery bypass is varied. This study sought to assess whether on-pump CABG procedu... This retrospective cohort study compared those with a PRU level ≤237 (low PRU group) to >237 (high PRU group). The primary outcome assessed massive or severe bleeding in accordance with universal defi... A total of 69 patients were included, 47 in the low and 22 in the high PRU groups. Patients were a median (IQR) 66 (62-74) years and 84.1% (N.=58) were male. Most patients received clopidogrel prior t... This study determined that low preoperative P2Y12 PRU levels may influence moderate bleeding in patients undergoing cardiac surgery, but not massive or severe bleeding....

Perioperative platelet reactivity over time in patients undergoing vascular surgery: An observational pilot study.

Despite Antiplatelet therapy (APT), cardiovascular patients undergoing revascularisation remain at high risk for thrombotic events. Individual response to APT varies substantially, resulting in insuff... To investigate residual platelet reactivity variability over time in individual patients undergoing carotid endarterectomy (CEA) treated with clopidogrel.... Platelet reactivity was determined in patients undergoing CEA in a prospective, single-centre, observational study using the VerifyNow (change in turbidity from ADP-induced binding to fibrinogen-coate... Between December 2017 and November 2019, 50 patients undergoing CEA were included. Platelet reactivity measured with the VerifyNow (p = < .001) and VASP (p = .029) changed over time, while the PACT di... In patients undergoing CEA, perioperative platelet reactivity measurements fluctuate over time with little agreement between platelet reactivity assays. Consequently, HTPR status of individual patient...

High-on-treatment platelet reactivity predicts adverse outcome after carotid artery stenting: A prospective study.

High-on-treatment platelet reactivity (HTPR) has been established as a predictor of major adverse cardiovascular events (MACE) in patients undergoing percutaneous coronary interventions on dual antipl... All consecutive patients treated with CAS in a single institution were enrolled in a prospective clinical study. HTPR was evaluated with 5 different laboratory assays carried out just before CAS. MACE... A total of 300 patients were enrolled in the study, and eight were then excluded because blood samples resulted unsuitable for the laboratory testing or CAS aborted for technical problems. Median foll... HTPR to three different assays (mainly to VASP + PFA P2Y+ VerifyNow) in patients on DAPT after CAS has predictive value for subsequent MACE. Prospective studies to assess whether platelet function tes...

Altered platelet reactivity, coagulation, endothelial and inflammatory markers early after smoking cessation verified with cotinine plasma concentration.

Cigarette smoking is a potent modifiable risk factor for coronary artery disease (CAD). However, little is known about alterations to prothrombotic state and platelet reactivity early after smoking ce... We investigated alterations to platelet reactivity, coagulation and markers of platelet, endothelial, inflammatory and coagulation activation in clopidogrel-treated patients with CAD after PCI before ... Smoking patients aged 18 years or older at least 30 days after PCI were recruited and encouraged to quit the habit. At baseline and at 30 days, we measured platelet reactivity with VerifyNow system, t... Among 117 patients, 84 patients (72%) at a median age of 60.5 years (40 [interquartile range 30-47] pack-years) completed a 30-day follow-up. At day 30, 30 (35.7%) patients stopped smoking with cotini... After smoking cessation in CAD patients following PCI an increase in platelet reactivity and a decrease in P-selectin levels were observed. The risk of thrombotic complications post PCI might be parad...